In a milestone move that promises to transform healthcare accessibility in the Philippines, PHILUSA Corporation forged a partnership with Bayer Philippines to bring forth a new era of world-class quality medicines at affordable prices through RHEA Generics. 

The ceremonial signing event was held at the Bayer Philippines Head Office on February 5, 2024, led by President and General Manager of PHILUSA Corporation Neogin Evangelista, Managing Director and Country Division Head of Bayer Philippines Angel Michaelo Evangelista, and Vice President for Merchandising of Mercury Drug Corporation Corazon Lim.

This partnership marks the 12th collaboration for RHEA Generics, with Bayer Philippines joining the roster of PHILUSA Corporation’s global pharmaceutical partners. Together, these industry giants aim to provide Filipino patients with an effective product for the prevention of stroke and treatment of thromboembolic events. “We’re here to help Filipino patients in accessing affordable generic medicines while ensuring their quality, safety, and efficacy,” said Mr. Neogin Evangelista.

PHILUSA President & General Manager Neogin Evangelista; Mercury Drug Corporation VP for Merchandising Corazon Lim; Bayer Philippines Managing Director and Country Division Head Corazon Lim with the PHILUSA Team

The Philippines, with its diverse demographic and varying lifestyle patterns, is witnessing an increase in cases of stroke. According to the Department of Health (DOH), stroke is included in the top three leading causes of death in the country, affecting both urban and rural populations. Mr. Angel Michaelo Evangelista shared that there are more than half a million patients affected by this disease, and the partnership aims to redefine the standards of healthcare affordability and availability. “Our mission is health for all. We are committed to ensuring that stroke-prevention medicine is available through our partner, RHEA Generics. This will provide enhanced patient access to high-quality and affordable medicine.” The wide distribution reach of Mercury Drug is also instrumental in making public health within reach. Ms. Corazon Lim stated, “Our customers are assured of availability, affordability, and accessibility.”’

PHILUSA President & General Manager Neogin Evangelista; Mercury Drug Corporation VP for Merchandising Corazon Lim; Bayer Philippines Managing Director and Country Division Head Corazon Lim with  the Bayer Team

Launched in 2014, RHEA Generics is a uni-brand of innovative generic medicines developed in partnership with global leaders in the pharmaceutical industry, namely: Pfizer, Viatris, Sanofi, GSK, Otsuka, Merck, Fresenius Kabi, OEP Philippines, Lundbeck, Boehringer Ingelheim, and AstraZeneca. Its portfolio of medicines includes treatments for hypertension, diabetes, hypercholesterolemia, respiratory infections, and chronic kidney disease, among others.

RHEA Generics are available at Mercury Drug Store branches nationwide. RHEA Generics products is a homegrown brand of PHILUSA Corporation and a pioneer in the generics industry with more than 40 years of experience in producing world-class quality and affordable healthcare products. For more information and updates, follow the social media pages RHEA Generics PH on Facebook and rheagenericsph on Instagram.